---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-109347"
form_type: "8-K"
ticker: "NEUP"
cik: "0001191070"
company_name: "Neuphoria Therapeutics Inc."
filed_at: "2024-12-16T23:59:59+00:00"
generated_at: "2026-05-29T02:48:34.980110+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Court approves Bionomics' re-domiciliation; Neuphoria to list Dec 24 under NEUP

## Summary
- Supreme Court of NSW approved Scheme of Arrangement on Dec 16, 2024; scheme became legally effective after lodgment with ASIC.
- Bionomics ADSs trade on Nasdaq through Dec 23, 2024; shareholders as of Dec 17 record date receive scheme consideration.
- Neuphoria Therapeutics Inc. shares expected to begin trading on Nasdaq under "NEUP" on Dec 24, 2024.
- Bionomics will become wholly-owned subsidiary of Neuphoria, re-domiciling from Australia to Delaware.

## SEC filing metadata
- accession: 0001213900-24-109347
- form_type: 8-K
- ticker: NEUP
- cik: 0001191070
- company_name: Neuphoria Therapeutics Inc.
- filed_at: 2024-12-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1191070/000121390024109347/0001213900-24-109347-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1191070/000121390024109347/ea0224864-8k_bionomics.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-109347
- JSON: https://secwatch.observer/filing/0001213900-24-109347.json
- Plain text: https://secwatch.observer/filing/0001213900-24-109347.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.